ClinicalTrials.gg
Drug

Islatravir clinical trials

Also written MK-8591.

studies test it
28
open now
2
in phase 3
11
first study started
2015

How each study uses islatravir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the islatravir studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
20 Apr 2026 · IDVYNSO · NDA 216964 (FDA, Drugs@FDA; in a combination)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Islatravir
14
ISL
8

Development codes

MK-8591
17

In one entry with another drug

Given together, or one or the other

DOR/ISL
11
Doravirine/islatravir
6

Studies by the year they started

28 studies that test it; most in 2020 (8)

Studies that test islatravir, by start year
YearStudies
20151
20171
20191
20208
20214
20221
20234
20244
20253
20261

By phase

A phase 1/2 study counts in both.

Phase 1
8
Phase 2
10
Phase 3
11

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 28 · Other 0

Merck Sharp & Dohme LLC (27) · Gilead Sciences (1)

Often tested with

Tested in the same studies.

Ulonivirine (4) · Doravirine (4) · Lamivudine (2) · Lenacapavir (1) · MK-8591A (1) · Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test islatravir.

Studies

Open first, then newest update. How each study uses islatravir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 28

See all 28 studies that test islatravir →

Codes

What other systems call islatravir · ClinicalTrials.gg INT005843

  • MeSH (NLM) C558823islatravirConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) QPQ082R25DISLATRAVIR ANHYDROUSConfirmed FDA, NLM, Wikidata
  • Wikidata Q24977417islatravirConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C174896IslatravirOne source FDA
  • DrugBank DB15653One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.